Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs
Abstract
Share and Cite
Blaess, M.; Csuk, R.; Schätzl, T.; Deigner, H.-P. Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. Int. J. Mol. Sci. 2024, 25, 9344. https://doi.org/10.3390/ijms25179344
Blaess M, Csuk R, Schätzl T, Deigner H-P. Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs. International Journal of Molecular Sciences. 2024; 25(17):9344. https://doi.org/10.3390/ijms25179344
Chicago/Turabian StyleBlaess, Markus, René Csuk, Teresa Schätzl, and Hans-Peter Deigner. 2024. "Elongation of Very Long-Chain Fatty Acids (ELOVL) in Atopic Dermatitis and the Cutaneous Adverse Effect AGEP of Drugs" International Journal of Molecular Sciences 25, no. 17: 9344. https://doi.org/10.3390/ijms25179344